Literature DB >> 24374014

Tumor suppressor p53 and its mutants in cancer metabolism.

Juan Liu1, Cen Zhang1, Wenwei Hu2, Zhaohui Feng3.   

Abstract

Tumor-suppressor p53 plays a key role in tumor prevention. As a transcription factor, p53 transcriptionally regulates its target genes to initiate different biological processes in response to stress, including apoptosis, cell cycle arrest or senescence, to exert its function in tumor suppression. Recent studies have revealed that metabolic regulation is a novel function of p53. Metabolic changes have been regarded as a hallmark of tumors and a key contributor to tumor development. p53 regulates many different aspects of metabolism, including glycolysis, mitochondrial oxidative phosphorylation, pentose phosphate pathway, fatty acid synthesis and oxidation, to maintain the homeostasis of cellular metabolism, which contributes to the role of p53 in tumor suppression. p53 is frequently mutated in human tumors. In addition to loss of tumor suppressive function, tumor-associated mutant p53 proteins often gain new tumorigenic activities, termed gain-of-function of mutant p53. Recent studies have shown that mutant p53 mediates metabolic changes in tumors as a novel gain-of-function to promote tumor development. Here we review the functions and mechanisms of wild-type and mutant p53 in metabolic regulation, and discuss their potential roles in tumorigenesis.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Metabolism; Mutant p53; Tumor suppressor; p53

Mesh:

Substances:

Year:  2013        PMID: 24374014      PMCID: PMC4069248          DOI: 10.1016/j.canlet.2013.12.025

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  75 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  Regulation of lipid metabolism by p53 - fighting two villains with one sword.

Authors:  Ido Goldstein; Varda Rotter
Journal:  Trends Endocrinol Metab       Date:  2012-07-20       Impact factor: 12.015

3.  p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2.

Authors:  Tanupriya Contractor; Chris R Harris
Journal:  Cancer Res       Date:  2011-11-28       Impact factor: 12.701

Review 4.  Mutant p53 gain-of-function in cancer.

Authors:  Moshe Oren; Varda Rotter
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

5.  ATP citrate lyase inhibition can suppress tumor cell growth.

Authors:  Georgia Hatzivassiliou; Fangping Zhao; Daniel E Bauer; Charalambos Andreadis; Anthony N Shaw; Dashyant Dhanak; Sunil R Hingorani; David A Tuveson; Craig B Thompson
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

Review 6.  The role of TP53 in Cervical carcinogenesis.

Authors:  Massimo Tommasino; Rosita Accardi; Sandra Caldeira; Wen Dong; Ilaria Malanchi; Anouk Smet; Ingeborg Zehbe
Journal:  Hum Mutat       Date:  2003-03       Impact factor: 4.878

7.  p53 Activation in adipocytes of obese mice.

Authors:  Naoya Yahagi; Hitoshi Shimano; Takashi Matsuzaka; Yuho Najima; Motohiro Sekiya; Yoshimi Nakagawa; Tomohiro Ide; Sachiko Tomita; Hiroaki Okazaki; Yoshiaki Tamura; Yoko Iizuka; Ken Ohashi; Takanari Gotoda; Ryozo Nagai; Satoshi Kimura; Shun Ishibashi; Jun-Ichi Osuga; Nobuhiro Yamada
Journal:  J Biol Chem       Date:  2003-05-06       Impact factor: 5.157

8.  Regulation of autophagy by cytoplasmic p53.

Authors:  Ezgi Tasdemir; M Chiara Maiuri; Lorenzo Galluzzi; Ilio Vitale; Mojgan Djavaheri-Mergny; Marcello D'Amelio; Alfredo Criollo; Eugenia Morselli; Changlian Zhu; Francis Harper; Ulf Nannmark; Chrysanthi Samara; Paolo Pinton; José Miguel Vicencio; Rosa Carnuccio; Ute M Moll; Frank Madeo; Patrizia Paterlini-Brechot; Rosario Rizzuto; Gyorgy Szabadkai; Gérard Pierron; Klas Blomgren; Nektarios Tavernarakis; Patrice Codogno; Francesco Cecconi; Guido Kroemer
Journal:  Nat Cell Biol       Date:  2008-05-04       Impact factor: 28.824

9.  Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion.

Authors:  Alice Bourdon; Limor Minai; Valérie Serre; Jean-Philippe Jais; Emmanuelle Sarzi; Sophie Aubert; Dominique Chrétien; Pascale de Lonlay; Véronique Paquis-Flucklinger; Hirofumi Arakawa; Yusuke Nakamura; Arnold Munnich; Agnès Rötig
Journal:  Nat Genet       Date:  2007-05-07       Impact factor: 38.330

Review 10.  The P53 pathway: what questions remain to be explored?

Authors:  A J Levine; W Hu; Z Feng
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

View more
  99 in total

Review 1.  RNA activation technique and its applications in cancer research.

Authors:  Xiao-Yu Wang; Long Yuan; Yan-Ling Li; Si-Jie Gan; Lin Ren; Fan Zhang; Jun Jiang; Xiao-Wei Qi
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

2.  P53 mutations and cancer: a tight linkage.

Authors:  Francesco Perri; Salvatore Pisconti; Giuseppina Della Vittoria Scarpati
Journal:  Ann Transl Med       Date:  2016-12

Review 3.  Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?

Authors:  Nissim Hay
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

4.  Regulation of glycolysis in head and neck squamous cell carcinoma.

Authors:  Dhruv Kumar
Journal:  Postdoc J       Date:  2017-01

Review 5.  Progress and problems with the use of suicide genes for targeted cancer therapy.

Authors:  Zahra Karjoo; Xuguang Chen; Arash Hatefi
Journal:  Adv Drug Deliv Rev       Date:  2015-05-22       Impact factor: 15.470

6.  The regulation of the p53/MDM2 feedback loop by microRNAs.

Authors:  Cen Zhang; Juan Liu; Xiaolong Wang; Zhaohui Feng
Journal:  RNA Dis       Date:  2015

Review 7.  Ceramide Signaling and p53 Pathways.

Authors:  Kristen A Jeffries; Natalia I Krupenko
Journal:  Adv Cancer Res       Date:  2018-06-01       Impact factor: 6.242

8.  Apoptosis induction of colorectal cancer cells HTL-9 in vitro by the transformed products of soybean isoflavones by Ganoderma lucidum.

Authors:  Mei-Lin Cui; Huan-Yi Yang; Guo-Qing He
Journal:  J Zhejiang Univ Sci B       Date:  2017 Dec.       Impact factor: 3.066

9.  Gain of function mutant p53 protein activates AKT through the Rac1 signaling to promote tumorigenesis.

Authors:  Xuetian Yue; Fangnan Wu; Yanchen Li; Juan Liu; Michael Boateng; Kranthi Mandava; Cen Zhang; Zhaohui Feng; Jimin Gao; Wenwei Hu
Journal:  Cell Cycle       Date:  2020-04-10       Impact factor: 4.534

10.  Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7.

Authors:  Kailiang Zhao; Yang Yang; Guang Zhang; Chenfeng Wang; Decai Wang; Mian Wu; Yide Mei
Journal:  EMBO Rep       Date:  2018-01-02       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.